Treatments for nervous disorders
AssigneePharmacia & Upjohn Company
InventorsFred Hassan, John Michael McCall, Duncan Paul Taylor, Philip F. Von Voigtlander, Erik Ho Fong Wong
Life of this patent
Estimating the term…
Abstract
This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and or Nicotine addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.
Claims1
A method of increasing a patient's attention span and calming a patient afflicted with attention deficit hyperactivity disorder, the method comprising the step of administering a therapeutically effective, nontoxic dose of reboxetine, reboxetine or pharmaceutically acceptable salts thereof to a patient.
Dependencies are inferred from the claim text.